A primer on precision medicine informatics

Briefings in Bioinformatics

Volumn 17, Issue 1, 2016, Pages 145-153

  Sboner, Andrea ^a   Elemento, Olivier ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Clinical genomics; Computational biology; Informatics; NGS testing; Precision medicine

Indexed keywords

BIOLOGY; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; GENETIC VARIATION; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; PERSONALIZED MEDICINE; PROCEDURES; SEQUENCE ALIGNMENT; SOFTWARE; STATISTICS AND NUMERICAL DATA; TRENDS;

COMPUTATIONAL BIOLOGY; DNA MUTATIONAL ANALYSIS; GENETIC VARIATION; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PRECISION MEDICINE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SOFTWARE;

EID: 84960121914     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbv032     Document Type: Article

References (80)

1. National Research Council (US) Committee on a framework for developing a new taxonomy of disease. In: Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington, DC, 2011.
2. Keutgen XM, Filicori F, Crowley MJ, et al. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res 2012;18(7):2032-8.
3. Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363(18):1693-703.
4. Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004;101(36):13306-11.
5. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353(16):1673-84.
6. Cancer Genome Atlas Research, N. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014; 511(7511):543-50.
7. Peters S, Michielin O, Zimmermann S. Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma. J Clin Oncol 2013;31(20):e341-4.
8. Zhu X, Petrovski S, Xie P, et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med 2015, online January 15:1-8.
9. Pao W, Wang TY, Riely GJ, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med 2005;2(1):e17.
10. Lazaridis KN, McAllister TM, Babovic-Vuksanovic D, et al. Implementing individualized medicine into the medical practice. Am J Med Genet C Semin Med Genet 2014;166C(1):15-23.
11. Van Allen EM, Wagle N, Stojanov P, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 2014;20(6):682-8.
12. Roychowdhury S, Iyer MK, Robinson DR, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med 2011;3(111):111ra121.
13. Beltran H, Eng K, Mosquera JM, et al. Whole exome sequencing of metastatic cancer and biomarkers of treatment response. JAMA Oncology 2015;1(4):466-74.
14. Servant N, Romejon J, Gestraud P, et al. Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial. Front Genet 2014;5:152.
15. Chen K, Meric-Bernstam F, Zhao H, et al. Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clin Chem 2015;61:544-53.
16. Frampton GM, Fichtenholtz A, Otto GA, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 2013;31(11):1023-31.
17. Brannon AR, Vakiani E, Sylvester BE, et al. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol 2014;15(8):454.
18. Forbes SA, Beare D, Gunasekaran P, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015;43:D805-11.
19. Diana MT, Mark JB, Elizabeth DH, et al. Integrating genetics into subspecialty care: The PulmoGene Test - comprehensive testing for hereditary causes of lung disease. In: A93. Immunologic and Genetic Biomarkers of Inflammatory Lung Disease. American Thoracic Society. International Conference, May 16-21, 2014, San Diego, CA, USA, A2175.
20. Nakamura K, Oshima T, Morimoto T, et al. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res 2011;39 (13):e90.
21. Bragg LM, Stone G, Butler MK, et al. Shining a light on dark sequencing: characterising errors in Ion Torrent PGM data. PLoS Comput Biol 2013;9(4):e1003031.
22. Salipante SJ, Kawashima T, Rosenthal C, et al. Performance comparison of Illumina and ion torrent next-generation sequencing platforms for 16S rRNA-based bacterial community profiling. Appl Environ Microbiol 2014;80(24):7583-91.
23. Schirmer M, Ijaz UZ, D'Amore R, et al. Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform. Nucleic Acids Res 2015;43(6):e37.
24. Gargis AS, Kalman L, Berry MW, et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 2012;30(11):1033-6.
25. Aziz N, Zhao Q, Bry L, et al. College of American pathologists' laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med 2015;139(4):481-93.
26. "Next Generation" Sequencing (NGS) guidelines for somatic genetic variant detection. http://www.wadsworth.org/labcert/TestApp roval/forms/NextGenSeq_ONCO_Guidelines.pdf.
27. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014;30(15): 2114-20.
28. Joshi NA, Fass JN. Sickle: A sliding-window, adaptive, qualitybased trimming tool for FastQ files 2011. https://github.com/ najoshi/sickle.
29. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25(14):1754-60.
30. Li R, Li Y, Kristiansen K, et al. SOAP: short oligonucleotide alignment program. Bioinformatics 2008;24(5):713-4.
31. DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011;43(5):491-8.
32. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001;29(1):308-11.
33. Garrison E, Marth G, Haplotype-based variant detection from short-read sequencing. arXiv 1207.3907 [q-bio.GN]
34. Koboldt DC, Chen K, Wylie T, et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 2009;25(17):2283-5.
35. Saunders CT, Wong WS, Swamy S, et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 2012;28(14):1811-7.
36. Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013;31(3):213-9.
37. Wang Q, Jia P, Li F, et al. Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers. Genome Med 2013;5(10):91.
38. Liu X, Han S, Wang Z, et al. Variant callers for next-generation sequencing data: a comparison study. PLoS One 2013;8(9): e75619.
39. Yi M, Zhao Y, JiaL, et al. Performance comparison of SNP detection tools with illumina exome sequencing data-an assessment using both family pedigree information and sample- matched SNP array data. Nucleic Acids Res 2014;42(12):e101.
40. Roberts ND, Kortschak RD, Parker WT, et al. A comparative analysis of algorithms for somatic SNV detection in cancer. Bioinformatics 2013;29(18):2223-30.
41. Zook JM, Chapman B, Wang J, et al. Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nat Biotechnol 2014;32(3):246-51.
42. Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014;42:D980-5.
43. Ye K, Schulz MH, Long Q, et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 2009;25(21):2865-71.
44. Narzisi G, O'Rawe JA, Iossifov I, et al. Accurate de novo and transmitted indel detection in exome-capture data using microassembly. Nat Methods 2014;11(10):1033-6.
45. Smith CC, Wang Q, Chin CS, et al. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature 2012;485(7397):260-3.
46. Carter SL, Cibulskis K, Helman E, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012;30(5):413-21.
47. Prandi D, Baca SC, Romanel A, et al. Unraveling the clonal hierarchy of somatic genomic aberrations. Genome Biol 2014; 15(8):439.
48. Olshen AB, Venkatraman ES, Lucito R, et al. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5(4):557-72.
49. Magi A, Tattini L, Cifola I, et al. EXCAVATOR: detecting copy number variants from whole-exome sequencing data. Genome Biol 2013;14(10):R120.
50. Fromer M, Moran JL, Chambert K, et al. Discovery and statistical genotyping of copy-number variation from wholeexome sequencing depth. Am J Hum Genet 2012;91(4):597-607.
51. Sathirapongsasuti JF, Lee H, Horst BAJ, et al. Exome Sequencing-Based Copy-Number Variation and Loss of Heterozygosity Detection: ExomeCNV, Bioinformatics 2011; 27(19):2648-54.
52. Berger MF, Lawrence MS, Demichelis F, et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470(7333):214-20.
53. McCarthy DJ, Humburg P, Kanapin A, et al. Choice of transcripts and software has a large effect on variant annotation. Genome Med 2014;6(3):26.
54. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010;38(16):e164.
55. Cingolani P, Platts A,Wang le L, et al. A programfor annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012;6(2):80-92.
56. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31(13):3812-4.
57. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7(4):248-9.
58. Peterson TA, Doughty E, Kann MG. Towards precision medicine: advances in computational approaches for the analysis of human variants. J Mol Biol 2013;425(21):4047-63.
59. Dorschner MO, Amendola LM, Shirts BH, et al. Refining the structure and content of clinical genomic reports. Am J Med Genet C Semin Med Genet 2014;166C(1):85-92.
60. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352(17):1779-90.
61. Zawati MH, Parry D, Thorogood A, et al. Reporting results fromwhole-genome and whole-exome sequencing in clinical practice: a proposal for Canada? J Med Genet 2014;51(1):68-70.
62. Gulley ML. Public policy recommendations for oversight of molecular laboratory tests. N C Med J 2007;68(2):109-11.
63. Smith LA, Douglas J, Braxton AA, et al. Reporting incidental findings in clinical whole exome sequencing: incorporation of the 2013 ACMG recommendations into current practices of genetic counseling. J Genet Couns. Published online 18 November 2014; doi: 10.1007/s10897-014-9794-4.
64. Amendola LM, Dorschner MO, Robertson PD, et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res 2015;25(3):305-15.
65. Deverka PA, Dreyfus JC. Clinical integration of next generation sequencing: coverage and reimbursement challenges. J Law Med Ethics 2014;42 (Suppl 1):22-41.
66. El-Kalioby M, Abouelhoda M, Kruger J, et al. Personalized cloud-based bioinformatics services for research and education: use cases and the elasticHPC package. BMC Bioinformatics 2012;13 (Suppl 17):S22.
67. Dove ES, Joly Y, Tasse AM, et al. Genomic cloud computing: legal and ethical points to consider. Eur J Hum Genet, 24 September 2014; doi: 10.1038/ejhg.2014.196.
68. Evanko D. The power of a crowd. Nat Methods 2014;11(1):31.
69. Hayden EC. Geneticists push for global data-sharing. Nature 2013;498(7452):16-7.
70. Laurent-Puig P, Pekin D, Normand C, et al. Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy. Clin Cancer Res 2015;21:1087-97.
71. Wang K, Singh D, Zeng Z, et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res 2010;38(18):e178.
72. Sboner A, Habegger L, Pflueger D, et al. FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biol 2010;11(10):R104.
73. Iyer MK, Chinnaiyan AM, Maher CA. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 2011;27(20):2903-4.
74. McPherson A, Hormozdiari F, Zayed A, et al. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 2011;7(5):e1001138.
75. Liberzon A, Subramanian A, Pinchback R, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011;27(12): 1739-40.
76. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102(43):15545-50.
77. Bonato P. Wearable sensors and systems. From enabling technology to clinical applications. IEEE Eng Med Biol Mag 2010;29(3): 25-36.
78. Quantified self. Fit, fit, hooray! 2013. http://www.economist. com/blogs/babbage/2013/05/quantified-self.
79. The Data-Driven Life. 2010. http://www.nytimes.com/2010/05/ 02/magazine/02self-measurement-t.html.
80. The Rise of the 'Quantified Self' in Health Care. 2013. http://blogs. wsj.com/venturecapital/2013/08/13/the-rise-of-the-quantifiedself- in-health-care/.